E0 ConsensusModerate confidencePEM not requiredSystematic-ReviewPeer-reviewedReviewed
Standard · 3 min
Systemic conditions associated with increased risk to develop oral squamous cell carcinoma: Systematic review and meta-analysis.
Dos Santos, Erison Santana, Pérez-de-Oliveira, Maria Eduarda, Normando, Ana Gabriela Costa et al. · Head & neck · 2022 · DOI
Quick Summary
This review looked at whether people with certain long-term health conditions—including chronic fatigue syndrome (ME/CFS)—are at higher risk for developing oral squamous cell carcinoma (a type of mouth cancer). Researchers analyzed data from over 1 million patients worldwide and found that people with ME/CFS, along with several rare genetic conditions and those who had bone marrow transplants, do have an increased risk. The study suggests doctors should pay special attention to mouth health in patients with these conditions.
Why It Matters
This study is important because it identifies ME/CFS as a systemic condition associated with increased oral cancer risk, potentially prompting targeted screening protocols for this vulnerable population. For ME/CFS researchers, this finding adds to the growing body of evidence that ME/CFS involves systemic dysfunction beyond fatigue, specifically affecting cancer surveillance and immune health. The results could inform clinical care guidelines and highlight a previously under-recognized complication requiring patient awareness.
Observed Findings
Chronic fatigue syndrome was identified as one of five systemic conditions associated with increased OSCC risk.
Overall prevalence of OSCC in syndromic patients was 0.65% (95% CI = 0.13–3.11).
OSCC prevalence in post-BMT patients was substantially higher at 5.83% (95% CI = 0.00–30.90).
Data were aggregated from studies encompassing more than 1 million patients worldwide.
Certainty of evidence was classified as moderate.
Inferred Conclusions
Certain systemic conditions, including ME/CFS, predispose patients to oral squamous cell carcinoma development.
Systemically compromised patients warrant enhanced OSCC screening and surveillance protocols.
Post-BMT patients showed notably higher OSCC prevalence than other syndromic groups, suggesting variable risk levels across conditions.
Remaining Questions
What is the biological or immunological mechanism linking ME/CFS to increased OSCC risk?
How does OSCC incidence in ME/CFS patients compare when controlling for known risk factors such as smoking, alcohol use, and viral exposures?
What This Study Does Not Prove
This study does not prove that ME/CFS directly causes oral cancer or explain the biological mechanism linking them. It is a prevalence analysis without controls or longitudinal follow-up; correlation alone does not establish causation, and unmeasured confounders (smoking, alcohol use, HPV exposure) may explain the association. The study also does not establish whether ME/CFS-specific pathophysiology or secondary effects drive the increased risk.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
Should ME/CFS patients receive routine oral cancer screening, and if so, at what age or frequency?
Is the association between ME/CFS and OSCC mediated by immune dysregulation, chronic inflammation, or secondary factors such as reduced antiviral immunity?